Journals / MN Oftalmoloji / 2015 / Cilt: 22 - Sayı: 2

Temporal Pterygium or Squamous Cell Carcinoma? Clinical Approach Through A Single Case

Temporal Pterjiyum mu Yassı Hücreli Karsinom mu? Bir Olgu Üzerinden Klinik Yaklaşım

Pages
118–120
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason a conjunctival lesion in an elderly patient with an atypical location, corneal invasion and a gelatinous grey-pink lesion should be approached with suspicion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Conjunctival squamous cell cancer (SSC) although very rare is the most common conjunctival malignancy.
📊
Key Findings & Data:Our patient, a 70 year old female presented wıth conjunctival burning and redness of 2-3 months duration.
💡
Conclusion & Impact:For this reason a conjunctival lesion in an elderly patient with an atypical location, corneal invasion and a gelatinous grey-pink lesion should be approached with suspicion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Conjunctival squamous cell cancer (SSC) although very rare is the most common conjunctival malignancy. Due to the rareness of this lesion, late diagnosis can result with orbita, lymph node and distant metastasis. Our patient, a 70 year old female presented wıth conjunctival burning and redness of 2-3 months duration. The lesion was excised and 0.02 % mitomycin C was prescribed as a neoadjuvant post- operatively. Since lesion was accompanied by other conjunctival degenerations, it might easily be missed with wrong diagnosis of tem poral pterygium. For this reason a conjunctival lesion in an elderly patient with an atypical location, corneal invasion and a gelatinous grey-pink lesion should be approached with suspicion.

Özet

Konjunktivanın yassı hücreli kanseri (YHK) nadir görülmesine rağmen konjunktivanın en sık görülen malignitesidir. Ender görülmesinden dolayı tanının gecikmesi göz küresi, orbita, lenf nodu invazyonu ve uzak organ yayılımı ile sonuçlanabilir. Bizim olgumuzda, 70 yaşında kadın hasta 2-3 aydır süren sol gözde yanma ve kızarıklık şikayeti ile başvurdu. Lezyon eksize edildi ve postoperatif neoadjuvan olar ak %0.02 mitomisin C damlası reçete edildi. Lezyona diğer konjunktiva dejenerasyonları eşlik ettiğinden temporal pterjiyum tanısıyla kolaylı kla gözden kaçırılabilirdi. Bu sebeple yaşlı hastalarda konjunktivada boyutu artan atipik yerleşimli, limbal korneayı invaze eden, jelatinim si, gri-pembe renkli lezyonlara şüphe ile yaklaşılmalıdır.

🔖

Cite This Article

YAZICI, A., SARI, E. S., TISKAOĞLU, N. S., PAKSOY, S., KILIÇ, A., ERMİŞ, S. S. (2022). Temporal Pterygium or Squamous Cell Carcinoma? Clinical Approach Through A Single Case. MN Oftalmoloji, Cilt: 22 - Sayı: 2, 118–120. https://ajindex.com/articles/581502

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol 2002;86(2):168-73
  2. Lee GA, Hirst LW. Incidence of ocular surface epithelial dyspla- sia in metropolitan Brisbane. A 10-year survey. Arch Ophthalmol 1992;110(4):525-7
  3. Basti S, Macsai MS. Ocular surface squamous neoplasia: a re- view. Cornea 2003;22:687-704
  4. Tunc M, Char DH, Crawford B, Miller T. Intraepithelial and in- vasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol 1999;83(1):98-103
  5. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39(6):429-50
  6. Buus DR, Tse DT, Folberg R, Buuns DR. Microscopically con- trolled excision of conjunctival squamous cell carcinoma. Am J Ophthalmol 1994;117(1):97-102
  7. Iliff WJ, Marback R, Green WR. Invasive squamous cell carci- noma of the conjunctiva. Arch Ophthalmol 1975;93(2):119-22
  8. Özgür ÖR EN, Oral Y, Doğan ÖK. Konjonktival Intraepitelyal Neoplazi Tedavisinde Cerrahi Eksizyon ile Birlikte Mitomisin-C Uygulaması ve Sonrası Topikal %0,002’lik Mitomisin-C Damla Uygulamasının Etkinliği. Turk J Ophthalmol 2011;41:138-42.